CRO
Richmond Pharmacology appoints Dr Edward Jackson as Medical Director
November 7, 2025CRO, Richmond Pharmacology, biotech, clinical trials
Richmond Pharmacology, a contract research organisation (CRO) specialising in first-in-human and adaptive clinical trials, has appointed Dr Edward Jackson as …
Ardena appoints new Chief Quality Officer and Chief Information Officer
November 6, 2025Ardena, CDMO, CRO, Chief Information Officer, chief quality officer
Ardena, a specialist pharmaceutical contract development and manufacturing organisation (CDMO) and bioanalytical contract research organisation (CRO) focusing on precision medicines, …
Crown Bioscience opens new US model development centre
September 19, 2025Medical Communications, Research and Development CRO, biotech, crown bioscience, life sciences
Crown Bioscience, a US global contract research organisation (CRO) that is part of JSR Life Sciences and Japan-based JSR Corporation, …
From molecule to market and beyond: Uniphar announces extended global commercialization platform
October 25, 2024CRO, UniPhar, cell and gene
22 October 2024 – Dublin, Ireland – Healthcare services business, Uniphar, has developed its full-service offering that harnesses Uniphar’s 55 …
Drug development contracts: can lessons be learned from healthcare delivery?
March 16, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CCG, CRO, Les Rose, NHS, drug development, trials
There is a very good question to ask at the beginning of every project: “What does success look like?” If …
LabCorp buys Covance for $6.1 billion
November 5, 2014Research and Development, Sales and Marketing CRO, Covance, king, labcorp, medical
US medical diagnostics firm LabCorp has entered the drug development business via a $6.1 billion deal to buy contract research …
Parexel acquires ClinIntel for trial supply services
October 6, 2014Manufacturing and Production CRO, Paraxel, clinical research organisation, clinintel, manufacturing
Clinical research organisation Parexel has acquired all of the outstanding equity securities of privately-owned ClinIntel, a UK-based provider of clinical …
Chiltern acquires Ockham to help lift status
July 16, 2014Manufacturing and Production CRO, chiltern, contract research, fsp, ockham
Chiltern has today acquired a full stake in fellow contract research organisation Ockham as both companies look to merge their …
New leadership roles at Novella Clinical
September 5, 2013Manufacturing and Production, Research and Development, Sales and Marketing CRO, novella clinical
Contract research organisation Novella Clinical has announced that three senior executives have assumed new leadership roles within the firm. Deborah …
Chiltern hires Andrew Monaghan as director
July 25, 2013Manufacturing and Production, Research and Development, Sales and Marketing CRO, chiltern, monaghan
Contract research organisation Chiltern has appointed Andrew Monaghan as its director of Global Pharmacovigilance. Monaghan has more than 30 years’ …
Contract research news in brief
September 4, 2012Research and Development CRO, Charles River, WuXi
Charles River Laboratories (CRL) has paid $17 million for Accugenix, a company which provides endotoxin detection and microbial identity testing …
Abbott sets out AbbVie stall for shareholders
June 12, 2012Manufacturing and Production AbbVie, Abbott, CRO, Taylor, manufacturing
Abbott Laboratories has issued the prospectus for its planned separation of its pharmaceutical operations into a standalone company called AbbVie …
Contract research news in brief
June 11, 2012Research and Development CRO, Complete Genomics, Foundation Medicine, Medtox Scientific and ERA Clinical, contract research, eResearch Technology
A round-up of news in the contract research services sector, including updates from Foundation Medicine, Complete Genomics, eResearch Technology, LabCorp …
ICON makes two senior appointments
May 21, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CRO, ICON, appointment
ICON has appointed Dr Susan Anton as director of epidemiology and risk management practice, and late phase and outcomes research. …
A more ‘nimble approach’ needed for CRO-pharma partnerships
April 10, 2012Research and Development CRO, partnerships
Pharma firms need to create closer and more flexible relationships with their contract research organisations for better outcomes. This is …
Latest content
FibroFind appoints Lee Borthwick as CEO
